Answers are grounded in this paper and cite their sources.
OBJECTIVES: This study aimed to evaluate how residual renal stone fragment size influences long-term stone-event-free survival after ureteroscopic lithotripsy (URSL), highlighting its clinical importance. METHODS: We retrospectively analyzed data from all patients who underwent URSL at our institution from 2008 to 2021. A total of 1334 cases were included and categorized into three groups based on their residual renal fragment size: 0 mm (1030 cases), < 4 mm (214 cases), and ≥ 4 mm (90 cases). Patient characteristics, surgical outcomes, and postoperative stone events were examined. Stone event-free survival rates were compared across these groups. RESULTS: During a mean follow-up of 763 days, 214 patients (16.0%) experienced stone events. The number of stone events in each group was 102 (9.9%) for 0 mm, 57 (26.6%) for < 4 mm, and 55 (61.1%) for ≥ 4 mm. The 1-year stone-event-free rates were 95.8%, 86.9%, and 44.9%, respectively, and the 5-year rates were 81.8%, 51.6%, and 28.0%. The reintervention-free rates at 1 year were 97.4%, 91.7%, and 50.5%, respectively, and at 5 years, they were 86.3%, 61.6%, and 35.5%. The log-rank test indicated significant differences in both stone-event-free and reintervention-free rates among the groups (p < 0.001). The multivariate Cox regression analysis revealed that the size of residual stones (0 mm versus < 4 mm and ≥ 4 mm) was the most significant factor in influencing stone events and re-interventions. CONCLUSIONS: The size of residual fragments after URSL significantly influences long-term outcomes, emphasizing the importance of meticulous stone removal for optimal patient care.
No takes yet. Share an insight, caveat, or question.
Tamiya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: